The Lacuna Project

lacuna (n.) a gap in a record where something should be

Independent research. Not affiliated with any government, agency, or company.

Chapter 9

Harm from Care

Abstract

Medical care kills and injures some of the patients it treats. Published estimates of the annual US death toll run from about 22,000 to about 251,000. The lowest figures count deaths that physician reviewers judged preventable, and the highest count every death from an adverse effect of care, including reactions to correctly prescribed drugs. A 2023 study of Massachusetts hospitals found an adverse event in nearly one admission in four. No direct, contemporary US study measures preventable hospital deaths, so every national figure is an extrapolation. Ivan Illich described this clinical harm in 1975 as the first of three levels of medically caused damage. Two randomized experiments and a national Medicare study found that additional care did not measurably improve average health. Studies of private equity ownership found more hospital-acquired conditions and higher nursing-home mortality after acquisition, and one found lower heart-attack mortality.

9.1 Six estimates, tenfold apart

§9.1.1

Six estimates of the number of Americans killed each year by medical care have shaped public discussion since 1998. They span a factor of about ten. They differ in the event counted, the population studied and the method used.

Estimates of US deaths from medical care
EstimateDeaths per yearWhat it countsMethod
Institute of Medicine, To Err Is Human (1999)44,000–98,000Deaths from medical error among hospital patientsExtrapolated from two adverse-event studies
Lazarou, Pomeranz and Corey (1998)106,000Fatal reactions to drugs used as prescribed, in hospital patients; errors excludedMeta-analysis of 39 prospective US hospital studies, applied to 1994
Starfield (2000)225,000All in-hospital deaths from adverse effects of care, error or not, including hospital infectionsSum of five published component estimates
Makary and Daniel (2016)251,454Deaths from medical errorPooled rates from four studies (2000–2008) applied to 35.4 million hospitalizations in 2013
Shojania and Dixon-Woods (2017)about 25,000Preventable deaths in hospitalRe-estimate within a critique of the error figures
Rodwin et al. (2020)about 22,165Hospital deaths judged preventable by physician reviewersMeta-analysis of 8 studies, 12,503 deaths, all from Canada and Europe
Finding MED-9.1Peer-reviewed

Published estimates of US deaths caused by medical care range from about 22,000 to about 251,000 a year. The range comes from what each study counts.

The lowest figures count deaths that physicians, reviewing the record afterward, judged preventable. The middle figures count deaths attributed to error. The highest count every death from an adverse effect of care, including reactions to drugs that were prescribed and given correctly. Rodwin's 22,165 and Starfield's 225,000 answer two different questions: how many hospital deaths a reviewer could have prevented, and how many deaths care caused.

Evidence: Exhibit 167, Exhibit 168, Exhibit 169, Exhibit 170, Exhibit 171, Exhibit 172

§9.1.2

The spread between the estimates comes from their definitions, and each figure follows from what it counts. Starfield's total, which is mostly harm without error, has been repeated as a count of medical error.

9.2 What each estimate counts

Finding MED-9.2Peer-reviewed

An estimated 106,000 hospitalized Americans died in 1994 from reactions to drugs that were correctly prescribed and given. These deaths are the largest component of the most-cited total of deaths from medical care.

Lazarou, Pomeranz and Corey pooled 39 prospective studies from US hospitals published between 1966 and 1996. They excluded errors in administration, noncompliance, overdose, drug abuse and therapeutic failure, so their count covers reactions to drugs used as directed. They estimated that in 1994, 2,216,000 hospitalized patients had serious reactions and 106,000 (range 76,000–137,000) died of them. On that estimate drug reactions ranked between the fourth and sixth leading cause of death in the United States.

Evidence: Exhibit 168, Exhibit 169

§9.2.1

Barbara Starfield used the Lazarou figure as the largest of five components in a 2000 JAMA commentary. The others were 12,000 deaths a year from unnecessary surgery, 7,000 from medication errors in hospitals, 20,000 from other errors in hospitals and 80,000 from hospital infections. Errors account for 39,000 of her 225,000. She noted that most of the data came from hospital patients and that the figures counted deaths only. Using the Institute of Medicine's higher error estimates, the total rose to between 230,000 and 284,000. She also cited an outpatient analysis that estimated 199,000 further deaths, which her total did not include.

§9.2.2

One secondary account states that Starfield's total excludes hospital infections. The published commentary lists them as its second-largest component, at 80,000 deaths a year.

§9.2.3

According to their 2016 BMJ paper, Makary and Daniel of Johns Hopkins estimated 251,454 deaths a year from medical error, 9.5 percent of US deaths. The paper pooled the error-death rates of four studies covering 2000 to 2008 and applied the pooled rate to 35,416,020 hospitalizations in 2013. Shojania and Dixon-Woods replied that three of the four studies contained 14, 12 and 9 deaths and that the authors "did not apply any established methodology for quantitative synthesis." Around 700,000 deaths occur in US hospitals each year, so an estimate of more than 250,000 preventable deaths implies that around a third or more of inpatient deaths result from medical error or preventable adverse events. Shojania and Dixon-Woods closed by calling such figures implausible estimates. At a 3.6 percent preventable rate they put preventable deaths at something like 25,000 a year.

§9.2.4

Rodwin and colleagues at Yale pooled eight studies in which physicians reviewed 12,503 hospital deaths. Reviewers judged 3.1 percent preventable (95% CI 2.2–4.1), which corresponds to about 22,165 US deaths a year. About 7,150 of those patients had been expected to live more than three months. In very sick patients, reviewers tend to assign death to the underlying illness, which pushes this method's estimate down.

§9.2.5

Starfield, and Makary and Daniel, each ranked their totals as the third leading cause of death in the United States. Neither total is comparable with the CDC's cause-of-death categories. Many of the patients counted also had heart disease or cancer, which the national tables already record as their cause of death.

9.3 Harm short of death

Finding MED-9.3Peer-reviewed

In 2018, 23.6 percent of sampled admissions to 11 Massachusetts hospitals had at least one adverse event, and 22.7 percent of the events were preventable.

Bates and colleagues drew a random sample of 2,809 admissions in 2018. Nurses screened each record with a trigger method, and physicians adjudicated each possible event. Of 978 adverse events, 222 were preventable and 316 were serious or worse. Preventable events affected 6.8 percent of admissions. Drug events made up 39.0 percent of all events, surgical and procedural events 30.4 percent, nursing-care events such as falls and pressure ulcers 15.0 percent, and health care-associated infections 11.9 percent. Seven patients died of adverse events, one of them preventably.

Evidence: Exhibit 173

Exhibit 173 · Peer-reviewed cohort study

The safety of inpatient health care

In a random sample of 2809 admissions, we identified at least one adverse event in 23.6%. Among 978 adverse events, 222 (22.7%) were judged to be preventable

Random sample of 2,809 admissions to 11 Massachusetts hospitals in 2018, screened by trained nurses with a trigger method and adjudicated by physicians. At least one adverse event occurred in 23.6 percent of admissions. Of 978 events, 222 (22.7 percent) were preventable and 316 (32.3 percent) were serious or worse. Preventable events affected 6.8 percent of admissions. Drug events were 39.0 percent of events, surgical or procedural 30.4, patient-care (including falls and pressure ulcers) 15.0, and health care-associated infections 11.9. Seven deaths occurred, one judged preventable. Funded by the Controlled Risk Insurance Company and the Risk Management Foundation of the Harvard Medical Institutions.

Source
Bates et al., New England Journal of Medicine 388(2):142–153
Date
12 January 2023
Quoted from
Abstract, Results (N Engl J Med 388(2):142-153)
Grade
Peer-reviewed
Document
https://doi.org/10.1056/NEJMsa2206117
Accessed
2026-11-09
Cited by
Findings citing this exhibit
§9.3.1

The Controlled Risk Insurance Company and the Risk Management Foundation of the Harvard Medical Institutions funded the study, and four of its authors held appointments there. The trigger method finds far more harm than reviews of deaths alone. Starfield's commentary states that its figures exclude harm that caused disability or discomfort, and the other five estimates in §9.1 also count deaths only. Shojania and Dixon-Woods argued that inflated death counts divert attention from the larger volume of non-fatal harm.

9.4 Who counts

Finding MED-9.4Open question

No direct, contemporary study measures how many US hospital deaths are preventable. Every national figure is an extrapolation from small, old or foreign samples.

The Institute of Medicine range came from two adverse-event studies. Makary and Daniel's rate came from four studies with small numbers of deaths. Rodwin's pooled studies all came from Canada and Europe, and Rodwin and colleagues called for a direct US study of preventable hospital deaths. Deaths outside hospitals, including those from outpatient prescribing, have no agreed estimate.

Evidence: Exhibit 172, Exhibit 171, Exhibit 170, Exhibit 167

Mechanism: The study not run

§9.4.1

Makary and Daniel argued that death certificates, coded to the International Classification of Diseases, cannot record medical error as a cause of death. Rodwin and colleagues noted that hospital mortality rates are used in quality measures and in reimbursement. Their meta-analysis found that the vast majority of hospital deaths are due to underlying disease.

§9.4.2

The national estimates come from an Institute of Medicine committee and from academic research groups, and the Massachusetts adverse-event study was funded by a malpractice insurer. No direct, current measurement of preventable deaths across US hospitals exists.

9.5 Illich: three levels of harm

Finding MED-9.5Primary record

In Medical Nemesis, Ivan Illich argued that professional medicine damages health at three levels, clinical, social and cultural, and that the cultural damage is the deepest.

Ivan Illich published Medical Nemesis in Britain in 1975 and in the United States in 1976. He organized the book by three levels of harm. He defined clinical iatrogenesis by the damage of treatment itself: "an expanding proportion of the new burden of disease of the last fifteen years is itself the result of medical intervention in favor of people who are or might become sick. It is doctor-made, or iatrogenic." Social iatrogenesis is "the medicalization of life," the title of the chapter that makes up the book's second part, which covers medical monopoly, dependence on professionals and the medicalization of the budget. Cultural iatrogenesis is the third and deepest level.

Evidence: Exhibit 174, Exhibit 175, Exhibit 176

Illich's three levels of iatrogenesis
LevelIllich's termsPart of the book
ClinicalDisease that is "doctor-made, or iatrogenic"Part I
Social"The medicalization of life": professional monopoly and dependencePart II
Cultural"The paralysis of healthy responses to suffering, impairment, and death"Part III
§9.5.1

Illich wrote that cultural iatrogenesis "is the ultimate backlash of hygienic progress and consists in the paralysis of healthy responses to suffering, impairment, and death. It occurs when people accept health management designed on the engineering model, when they conspire in an attempt to produce, as if it were a commodity, something called 'better health.'" He called the three levels together "this self-reinforcing loop of negative institutional feedback" and named it medical nemesis, after the Greek goddess who punished hubris. Commentators note that clinical harm, the level most associated with his name, received the least space in the book.

Exhibit 174 · Book

Medical Nemesis: The Expropriation of Health

This cultural iatrogenesis, which I shall discuss in Part III, is the ultimate backlash of hygienic progress and consists in the paralysis of healthy responses to suffering, impairment, and death.

Argues that professional medicine damages health at three levels: clinical iatrogenesis (Part I), social iatrogenesis or 'the medicalization of life' (Part II) and cultural iatrogenesis (Part III). Names the self-reinforcing loop among them 'medical nemesis' and proposes a political remedy, the recovery of lay self-care and legal limits on the professional monopoly of physicians. Credits immunization against polio, whooping cough and measles, smallpox vaccination of infants, antibiotics and oral rehydration, while arguing that effective interventions are few and cheap and that medical treatment is not significantly related to the population-level fall in disease.

Source
Ivan Illich (Pantheon Books, New York)
Date
1976 (British text copyright 1975)
Quoted from
Part I, ch. 1 'The Epidemics of Modern Medicine', section 'Defenseless Patients'
Grade
Primary record
Document
https://archive.org/details/medicalnemesisex00illi
Accessed
2026-11-09
Cited by
Findings citing this exhibit
§9.5.2

His remedy was political. Medical nemesis "can be reversed only through a recovery of the will to self-care among the laity, and through the legal, political, and institutional recognition of the right to care, which imposes limits upon the professional monopoly of physicians." He added, "I do not suggest any specific forms of health care or sick-care."

§9.5.3

The sentence most often quoted from the book, "The medical establishment has become a major threat to health," opens the Introduction to Limits to Medicine, the British edition of 1976. The Pantheon US edition does not contain it. That edition's first chapter opens instead by observing that "Polio, diphtheria, and tuberculosis are vanishing" and that "there is in fact no evidence of any direct relationship between this mutation of sickness and the so-called progress of medicine."

Exhibit 175 · Book

Limits to Medicine. Medical Nemesis: The Expropriation of Health

The medical establishment has become a major threat to health.

The British edition, described by its publisher as the definitive version of Medical Nemesis. Its Introduction opens with the sentence most often quoted from the book. The Pantheon US edition of the same year does not contain that sentence and opens its first chapter on the decline of polio, diphtheria and tuberculosis.

Source
Ivan Illich (Calder & Boyars, London; reprinted by Marion Boyars)
Date
1976 (preface dated 27 February 1976)
Quoted from
Introduction, first sentence
Grade
Primary record
Document
https://archive.org/details/limitstomedicine0000illi
Accessed
2026-11-09
Cited by
Findings citing this exhibit
§9.5.4

Illich credited specific vaccines by name, writing that "Immunization has almost wiped out paralytic poliomyelitis" and that vaccines "have certainly contributed to the decline of whooping cough and measles," and he listed smallpox vaccination of infants among effective techniques. His argument concerned populations: "the specifically medical treatment of people is never significantly related to a decline in the compound disease burden or to a rise in life expectancy." For that claim he relied on Thomas McKeown's thesis that better nutrition drove the historical fall in mortality. Colgrove's 2002 review in the American Journal of Public Health reports that McKeown's thesis remained influential "in spite of his conclusions' having been largely discredited by subsequent research."

9.6 More care, same average health

Finding MED-9.6Peer-reviewed

In two randomized experiments, more generous insurance increased the use of care without measurably improving average physical health.

The RAND Health Insurance Experiment, which ran from 1971 to 1982, randomly assigned families to plans ranging from free care to 95 percent coinsurance. Families on the 95 percent plan spent about 30 percent less than families with free care, and the principal 1987 analysis put free-plan spending about 45 percent higher. Cost sharing cut physician visits by one to two a year and hospitalizations by 20 percent, with no measurable effect on the health of the average participant. The exceptions were people with poor vision and low-income people with high blood pressure, who did better under free care.

In 2008 Oregon drew about 30,000 names by lottery from a Medicaid waiting list of almost 90,000 people. About two years later, Baicker and colleagues compared 6,387 adults selected in the lottery with 5,842 who were not. Coverage had no significant effect on hypertension, high cholesterol or average glycated hemoglobin. It increased diabetes diagnosis and treatment, lowered positive depression screens by 9.15 percentage points, and nearly eliminated catastrophic out-of-pocket spending. The confidence intervals on the physical measures were wide enough to include clinically meaningful benefits.

Evidence: Exhibit 177, Exhibit 178, Exhibit 179

Mechanism: Revenue from the problem

Finding MED-9.7Peer-reviewed

Medicare patients in the highest-spending regions received about 60 percent more care and had no better survival, quality of care, access or satisfaction.

Fisher and colleagues at Dartmouth followed Medicare patients hospitalized in 1993–1995 for hip fracture (614,503), colorectal cancer (195,429) or heart attack (159,393), together with a survey sample of 18,190. Patients in the highest-spending regions had similar baseline health and received about 60 percent more care, mainly inpatient visits, specialist consultations, tests and hospital and intensive-care days. Quality was no better on most measures and worse on several preventive measures. Each 10 percent increase in regional end-of-life spending was associated with a slightly higher risk of death for colorectal cancer patients (relative risk 1.012) and heart-attack patients (1.007).

Evidence: Exhibit 180, Exhibit 181

Mechanism: Revenue from the problem

§9.6.1

All three studies measured care added above a basic level. Where a cheap, effective treatment met an unmet need, as with blood-pressure control and eyeglasses for poor participants in RAND, more care improved health. Illich made the same distinction in 1976 when he credited a short list of inexpensive interventions.

9.7 Who owns the hospital

Finding MED-9.8Peer-reviewed

After private equity acquisition, hospital-acquired conditions rose at acquired hospitals and patient mortality rose at acquired nursing homes. A third study found lower heart-attack mortality at acquired hospitals.

Kannan, Bruch and Song compared 51 hospitals acquired by private equity with 259 matched hospitals in Medicare claims from 2009 to 2019. After acquisition, hospital-acquired conditions rose by 4.6 per 10,000 admissions (95% CI 2.0–7.2), a 25.4 percent increase over a baseline of 18.1. The measure sums conditions, so one admission can contribute several. Thirty-day mortality showed no differential change. Gupta and colleagues estimated an 11 percent relative increase in mortality among nursing-home patients after private equity acquisition, adjusted for the lower-risk patients the acquired homes admitted. They also reported declines in staffing and in compliance with care standards.

Evidence: Exhibit 182, Exhibit 183, Exhibit 184, Exhibit 185

Mechanism: Revenue from the problem

§9.7.1

Cerullo and colleagues examined more than 21 million Medicare records for five acute conditions from 2001 to 2018. Acquisition was associated with lower heart-attack mortality, by 1.14 percentage points in hospital and 1.41 points within 30 days (95% CI 0.56–2.26). Mortality for stroke, heart failure, COPD exacerbation and pneumonia did not change significantly, and readmissions and 30-day spending did not differ. Their follow-up ended three years after acquisition.

§9.7.2

Borsa and colleagues reviewed 55 studies of private equity ownership in health care, 47 of them from the United States, of which 32 assessed impacts. Nine of twelve studies found higher costs to patients or payers, three found no difference, and none found lower costs. Quality results were mixed and more often adverse. Health outcomes had too few studies for a general conclusion.

§9.7.3

Kannan's team proposed staffing cuts as an explanation and did not test them. Gupta's estimate rests on an instrument based on distance to nursing homes and applies to patients whose placement that distance changes. In November 2023 the Centers for Medicare & Medicaid Services issued a final rule requiring nursing homes to disclose additional owners and managers, including parties with financial control, property lessors and providers of administrative services.

Exhibit 186 · Agency fact sheet

Disclosures of ownership and additional disclosable parties information for skilled nursing facilities and nursing facilities (final rule fact sheet)

Announces a final rule requiring nursing homes to disclose additional owners and managers, including parties with financial control, property lessors and providers of administrative or cash-management services, and describes identifying private equity and real estate investment trust ownership in enrollment records. The rule was published in the Federal Register on 17 November 2023.

Source
Centers for Medicare & Medicaid Services
Date
15 November 2023
Grade
Primary record
Document
https://www.cms.gov/newsroom/fact-sheets/disclosures-ownership-additional-disclosable-parties-information-skilled-nursing-facilities-nursing
Accessed
2026-11-09
Cited by
Findings citing this exhibit
Note
Records the disclosure requirement only; implementation and enforcement were not reviewed.

9.8 What the counts measure

§9.8.1

The harm documented in this chapter runs from reactions to correctly prescribed drugs, through preventable error, to conditions acquired in hospital after a change of owner. The drug-trial record on which prescribing rests is itself filtered toward favorable results, as Chapter 4 documents (Finding 4.1).

§9.8.2

The national death counts in public use are extrapolations from small, old or foreign samples, and none measures harm outside hospitals. Rodwin and colleagues called for a direct US study of preventable hospital deaths in 2020.

Key findings

  1. Estimates of US deaths from medical care range from about 22,000 to about 251,000 a year because each counts a different thing (9.1).
  2. Reactions to correctly prescribed drugs were estimated to kill 106,000 hospital patients in 1994, the largest component of the most-cited total (9.2).
  3. Nearly one hospital admission in four had an adverse event in 2018, and more than a fifth of the events were preventable (9.3).
  4. No direct, contemporary study measures preventable US hospital deaths (9.4).
  5. Illich described clinical, social and cultural harm from medicine, and credited specific vaccines (9.5).
  6. More generous insurance and higher regional spending produced more care without better average health (9.6, 9.7).
  7. Private equity acquisition was followed by more hospital-acquired conditions and higher nursing-home mortality, with one study finding lower heart-attack mortality (9.8).

Version 0.1. Last updated 9 November 2026. Report an error.